Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter Study Evaluating the Safety and Performance of the NuVasive® ACP System for the Treatment of Patients With Pathologic Conditions of the Cervical Spine

NCT05066711 is registered in ClinicalTrials.gov with NuVasive as lead sponsor.

NCT NCT05066711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05066711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter Study Evaluating the Safety and Performance of the NuVasive® ACP System for the Treatment of Patients With Pathologic Conditions of the Cervical Spine
Lead sponsor
NuVasive
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 22, 2022
Completion date
June 30, 2027
Enrollment
75 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical disc disease, cervical disc herniation, cervical myelopathy, cervical radiculopathy, cervical spine disease, cervical spondylosis, cervical stenosis